Topics

RB's OTC Sales Slump 9% In Q1 As Cold Season Fails To Materialize

02:47 EDT 3 May 2019 | SCRIP

Reckitt Benckiser was hit badly by the weak cold and flu season in the US and Europe at the start...

      

Related Stories

 

Original Article: RB's OTC Sales Slump 9% In Q1 As Cold Season Fails To Materialize

NEXT ARTICLE

More From BioPortfolio on "RB's OTC Sales Slump 9% In Q1 As Cold Season Fails To Materialize"

Quick Search